Implants News and Research RSS Feed - Implants News and Research

Antimicrobial coating for portable communication devices developed by Lucideon and King’s

Antimicrobial coating for portable communication devices developed by Lucideon and King’s

International materials technology specialist Lucideon has developed a new infection control method to tackle problems associated with digital technology in hospitals. [More]
NeoGraft selects Verasoni Worldwide as marketing communications partner

NeoGraft selects Verasoni Worldwide as marketing communications partner

NeoGraft is pleased to announce the selection of Verasoni Worldwide as integrated marketing communications partner. NeoGraft is a world leader in hair replacement technology serving physicians and patients in the United States and around the world. NeoGraft is the first Class One FDA Listed automated medical device for hair restoration. [More]
Fluorescent material can reveal growth of cells inside living tissue

Fluorescent material can reveal growth of cells inside living tissue

Fibre from a semiconducting polymer, developed for solar cells, is an excellent support material for the growth of new human tissue. Researchers at Linköping University have shown that the fibre glows, which makes it possible to follow the growth of the cells inside living tissue. [More]
HeartWare announces initiation of MVAD System CE Mark international clinical trial

HeartWare announces initiation of MVAD System CE Mark international clinical trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced commencement of its MVAD System CE Mark international clinical trial. [More]
Alternative limb-lengthening technique makes recovery process less cumbersome

Alternative limb-lengthening technique makes recovery process less cumbersome

A highly specialized procedure that lengthens bones can prevent the need for amputations in selected patients who have suffered severe fractures. [More]
Impingement testing added to Lucideon’s orthopedic implant testing services

Impingement testing added to Lucideon’s orthopedic implant testing services

Lucideon, the international materials technology company, has added impingement testing to its range of services for orthopedic implant manufacturers. [More]
Brett Lee named Cochlear's first Global Hearing Ambassador

Brett Lee named Cochlear's first Global Hearing Ambassador

Australian cricket great, Brett Lee, was today announced as Cochlear's first Global Hearing Ambassador. As one of the world's fastest bowlers, who has smashed multiple cricket records, Brett's new target is 360 million people - and raising awareness about hearing loss. [More]
High-frequency tympanometry testing can help identify middle-ear problems in newborn babies

High-frequency tympanometry testing can help identify middle-ear problems in newborn babies

Screening newborn babies who are in the neonatal intensive care unit (NICU) using a testing process called high-frequency tympanometry can help identify middle-ear problems earlier, according to newly published research from a local team of researchers. [More]

Researchers develop new approach for better integrating medical devices with biological systems

Researchers have developed a new approach for better integrating medical devices with biological systems. The researchers, led by Bozhi Tian, assistant professor in chemistry at the University of Chicago, have developed the first skeleton-like silicon spicules ever prepared via chemical processes. [More]
Sepsis readmissions have significant impact on health care expenditures in California

Sepsis readmissions have significant impact on health care expenditures in California

The Affordable Care Act created several national initiatives aimed at reducing hospital readmission rates for heart attacks, congestive heart failure and other common high-risk conditions. But there is still no national program intended to address sepsis, a potentially life-threatening illness caused by infection. [More]
Dental pulp stem cell transplants can contribute to peripheral nerve regeneration

Dental pulp stem cell transplants can contribute to peripheral nerve regeneration

Peripheral nerve injuries often are caused by trauma or surgical complications and can result in considerable disabilities. Regeneration of peripheral nerves can be accomplished effectively using autologous (self-donated) nerve grafts, but that procedure may sacrifice a functional nerve and cause loss of sensation in another part of the patient's body. [More]
WATCHMAN Device helps reduce stroke risk, stop use of blood thinners in patients with atrial fibrillation

WATCHMAN Device helps reduce stroke risk, stop use of blood thinners in patients with atrial fibrillation

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning medication. Physicians at MedStar Heart at MedStar Washington Hospital Center were the first in the Washington metropolitan region to successfully implant the WATCHMAN Device on June 16 in two patients with atrial fibrillation (A-fib). [More]
Afamelanotide treatment improves quality of life in people with erythropoietic protoporphyria

Afamelanotide treatment improves quality of life in people with erythropoietic protoporphyria

A novel synthetic hormone that makes certain skin cells produce more melanin significantly increases pain-free sun exposure in people with erythropoietic protoporphyria, a rare, genetic disorder resulting in excruciating pain within minutes of sun exposure. [More]

Strong Precision Technologies' two medical divisions now going to market under MedTorque brand

Strong Precision Technologies announced today that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. [More]
FDA Grants clearance to MXO's dynaMX Compression Staple featuring Malleable Nitinol Technology

FDA Grants clearance to MXO's dynaMX Compression Staple featuring Malleable Nitinol Technology

MX Orthopedics, Corp., a leader in superelastic technologies for orthopedic implants, announces the recent FDA clearance (K143622) of its patent-pending dynaMX™ Compression Staple featuring Malleable Nitinol Technology. [More]
Implantable microfluid system can efficiently stabilize intraocular pressure

Implantable microfluid system can efficiently stabilize intraocular pressure

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, Fraunhofer researchers are developing an implantable microfluid system that can efficiently and durably stabilize intraocular pressure. [More]
FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone interbody device by the U.S. Food and Drug Administration (FDA). [More]
STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

Many patients with advanced cancers experience significant pain, and the pain caused by metastases (cancers that have spread to the spine) can be excruciating as tumor growth replaces bone. [More]
Cochlear Nucleus 6 Sound Processor approved by FDA for use with Nucleus 22 Cochlear Implant

Cochlear Nucleus 6 Sound Processor approved by FDA for use with Nucleus 22 Cochlear Implant

Cochlear Limited, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Cochlear™ Nucleus® 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning (over 20 years in some cases) access to the latest breakthroughs in true wireless and automatic hearing. Released in 1985, the Nucleus 22 Implant was the first commercially available multi-channel cochlear implant in the world. [More]
CardiAQ Valve Technologies announces first human implant of transcatheter bioprosthetic mitral heart valve

CardiAQ Valve Technologies announces first human implant of transcatheter bioprosthetic mitral heart valve

CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical transfemoral-transseptal percutaneous Transcatheter Mitral Valve Implantation (TMVI), today announced that its second-generation bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment into a 72-year-old male suffering from severe mitral regurgitation (MR 4+) with multiple co-morbidities and ineligible for alternate treatment modalities. [More]
Advertisement
Advertisement